April Lewis, GM of Hū, part of Real Chemistry

Most recent articles by April Lewis, GM of Hū, part of Real Chemistry

What if digitalization could democratize clinical trials?

March 26, 2021

12:00 pm

DCTs or hybrid trials support patient needs in ways that traditional clinical trials have not been able to meet.

From Our Partners

Partner Content

Native advertising is exploding across healthcare, have you jumped in?

In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing.

Partner Content

Digital healthcare transformation

The dark downsides and how marketers can address.

Partner Content

The pitfalls of data-driven planning

As many marketers begin planning for 2022, John Gardner and Kamala Prince from Luckie will talk about how to resolve these issues to set up a successful, and measurable, 2022.

Partner Content

MM+M Podcast with Ashfield Health

When every clinical, commercial, or marketing decision impacts a human life, choosing the right healthcare intelligence platform matters. And when an impossible amount of data exists, waiting to be harnessed, connected, and purposed, choosing Gravity.ai means you pinpoint the moments that matter most—every time.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

April Lewis, GM of Hū, part of Real Chemistry

Most recent articles by April Lewis, GM of Hū, part of Real Chemistry

What if digitalization could democratize clinical trials?

Culture drives the company

From Our Partners

Partner Content

Native advertising is exploding across healthcare, have you jumped in?

Partner Content

Digital healthcare transformation

Partner Content

The pitfalls of data-driven planning

Partner Content

MM+M Podcast with Ashfield Health

Thank you for accessing MM+M.